CASE REPORT
A rare cause of short stature: Kenny-Caffey syndrome type 2 – a case report and literature review
 
More details
Hide details
1
Department of Paediatrics, Paediatric Endocrinology, and Diabetes, Medical College, University of Rzeszów, Rzeszów, Poland
 
2
Students’ Scientific Association of Clinical Genetics, Department of Clinical Genetics, Medical College, University of Rzeszów, Rzeszów, Poland
 
3
Students’ Scientific Association of Paediatrics, Department of Paediatrics, Medical College, University of Rzeszów, Rzeszów, Poland
 
4
Department of Clinical Genetics, Medical College, University of Rzeszów, Rzeszów, Poland
 
 
Submission date: 2020-06-03
 
 
Final revision date: 2020-10-03
 
 
Acceptance date: 2020-10-04
 
 
Publication date: 2021-01-30
 
 
Pediatr Pol 2020;95(4):249-254
 
KEYWORDS
TOPICS
ABSTRACT
Kenny-Caffey syndrome type 2 is a very rare disease characterized by short stature, skeleton and eye abnormalities, hypoparathyroidism, hypocalcemia, and normal intellectual development. It is caused by a mutation in the FAM111A gene and inherited in an autosomal dominant way. It occurs at a frequency of 1 : 1 000 000. Less than 100 cases had been described to date. Treatment in this disease is only symptomatic and the use of growth hormone does not give satisfying effects. We present a case of a 12-year-old boy with short stature, hypoparathyroidism, hypothyroidism, and hyperopia. The next-generation sequencing study revealed a mutation (R569H) in one allele of the above-mentioned gene. On the basis of the clinical picture and special investigations results, Kenny-Caffey syndrome type 2 was diagnosed.
REFERENCES (17)
1.
National Organization for Rare Disorders. Kenny-Caffey Syndrome. 2012. https://rarediseases.org/rare-... (access: May 14th 2020).
 
2.
Orphanet. https://www.orpha.net/consor/c... (access: May 14th 2020).
 
3.
Kenny FM, Linarelli L. Dwarfism and cortical thickening of tubular bones. Transient hypocalcemia in a mother and son. Am J Dis Child 1966; 111: 201-207.
 
4.
Unger S, Górna MW, Le Béchec A, et al. FAM111A mutations result in hypoparathyroidism and impaired skeletal development. Am J Hum Genet 2013; 92: 990-995.
 
5.
Abdel-Al YK, Auger LT, el-Gharbawy F. Kenny-Caffey syndrome. Case report and literature review. Clin Pediatr (Phila) 1989; 28: 175-179.
 
6.
Abraham MB, Li D, Tang D, et al. Short stature and hypoparathyroidism in a child with Kenny-Caffey syndrome type 2 due to a novel mutation in FAM111A gene. Int J Pediatr Endocrinol 2017; 2017: 1.
 
7.
Caffey J. Congenital stenosis of medullary spaces in tubular bones and calvaria in two proportionate dwarfs--mother and son; coupled with transitory hypocalcemic tetany. Am J Roentgenol Radium Ther Nucl Med 1967; 100: 1-11.
 
8.
Online Mendelian Inheritance in Man. http://www.omim.org/entry/1270.... Last edited 06/02/2017 (access: May 14th 2020).
 
9.
Bove-Fenderson E, Mannstadt M. Hypocalcemic disorders. Best Pract Res Clin Endocrinol Metab 2018; 32: 639-656.
 
10.
Majewski F, Rosendahl W, Ranke M, et al. The Kenny syndrome, a rare type of growth deficiency with tubular stenosis, transient hypoparathyroidism and anomalies of refraction. Eur J Pediatr 1981; 136: 21-30.
 
11.
Pyrżak B, Walczak M. Endokrynologia wieku rozwojowego. PZWL Wydawnictwo Lekarskie, Warszawa 2018.
 
12.
Isojima T, Doi K, Mitsui J, et al. A recurrent de novo FAM111A mutation causes Kenny-Caffey syndrome type 2. J Bone Miner Res 2014; 29: 992-998.
 
13.
Moussaid Y, Griffiths D, Richard B, et al. Oral manifestations of patients with Kenny-Caffey Syndrome. Eur J Med Gen 2012; 55: 441-445.
 
14.
Boynton JR, Pheasant TR, Johnson BL, et al. Ocular findings in Kenny’s syndrome. Arch Ophthalmol 1979; 97: 896-900.
 
15.
Enriquez EJ, Toledo F, Bustamante-Cruz M, et al. Congenital medullary tubular stenosis. A case report of Caffey-Kenny syndrome. Acta Orthop Scand 1988; 59: 326-327.
 
16.
Hoffman WH, Kovacs K, Li S, et al. Kenny-Caffey syndrome and microorchidism. Am J Med Genet 1998; 80: 107-111.
 
17.
Miller DT, Adam MP, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies. Am J Hum Genet 2010; 86: 749-764.
 
Journals System - logo
Scroll to top